ZTS Zoetis Inc.

NYSE zoetis.com


$ 120.42 $ 0.13 (0.11 %)    

Tuesday, 11-Nov-2025 15:44:52 EST
QQQ $ 621.93 $ 1.33 (0.21 %)
DIA $ 479.57 $ 5.46 (1.15 %)
SPY $ 683.12 $ 3.14 (0.46 %)
TLT $ 89.97 $ 0.03 (0.03 %)
GLD $ 379.88 $ -0.13 (-0.03 %)
$ 119.79
$ 120.50
$ 120.41 x 107
$ 120.46 x 129
$ 119.59 - $ 121.29
$ 117.26 - $ 179.47
4,828,419
na
52.79B
$ 0.85
$ 19.91
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-04-2025 09-30-2025 10-Q
2 08-05-2025 06-30-2025 10-Q
3 05-06-2025 03-31-2025 10-Q
4 02-13-2025 12-31-2024 10-K
5 11-04-2024 09-30-2024 10-Q
6 08-06-2024 06-30-2024 10-Q
7 05-02-2024 03-31-2024 10-Q
8 02-13-2024 12-31-2023 10-K
9 11-02-2023 09-30-2023 10-Q
10 08-08-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 02-14-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 02-15-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 02-16-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-06-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-13-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-06-2019 08-06-2019 10-Q
27 05-02-2019 03-31-2019 10-Q
28 02-14-2019 12-31-2018 10-K
29 11-01-2018 09-30-2018 10-Q
30 08-02-2018 06-30-2018 10-Q
31 05-02-2018 03-31-2018 10-Q
32 02-15-2018 12-31-2017 10-K
33 11-02-2017 10-01-2017 10-Q
34 08-08-2017 07-02-2017 10-Q
35 05-04-2017 04-02-2017 10-Q
36 02-16-2017 12-31-2016 10-K
37 11-03-2016 10-02-2016 10-Q
38 08-05-2016 07-03-2016 10-Q
39 05-06-2016 04-03-2016 10-Q
40 02-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 zoetis-acquires-veterinary-pathology-group-to-strengthen-veterinary-diagnostics-in-uk-and-ireland-no-financial-terms-disclosed

Zoetis Inc. today announced the acquisition of Veterinary Pathology Group (VPG), a leading veterinary diagnostic laboratory gro...

 morgan-stanley-maintains-overweight-on-zoetis-lowers-price-target-to-175

Morgan Stanley analyst Erin Wright maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $211 to $175.

 ubs-maintains-neutral-on-zoetis-lowers-price-target-to-141

UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target from $158 to $141.

 jp-morgan-maintains-overweight-on-zoetis-lowers-price-target-to-200

JP Morgan analyst Chris Schott maintains Zoetis (NYSE:ZTS) with a Overweight and lowers the price target from $230 to $200.

 zoetis-stock-outlook-clouded-by-rising-competitive-pressures

Zoetis tops Q3 earnings estimates but trims 2025 sales forecast as companion animal growth slows and competition weighs on its ...

 zoetis-affirms-fy2025-adj-eps-guidance-of-630-640-vs-635-est-lowers-fy2025-sales-guidance-from-9450b-9600b-to-9400b-9475b-vs-9516b-est

Zoetis (NYSE:ZTS) affirms FY2025 Adj EPS guidance from $6.30-$6.40 to $6.30-$6.40 vs $6.35 analyst estimate. Lowers FY2025 sale...

 zoetis-q3-adj-eps-170-beats-162-estimate-sales-2400b-miss-2411b-estimate

Zoetis (NYSE:ZTS) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.62 by 4.81 per...

 zoetis-portela-granted-european-commissions-marketing-authorization

Zoetis Inc. today announced that the European Commission has granted the company marketing authorization for Portela® (relfovet...

 zoetis-stock-outlook-remains-muted

Adhishthana.com analysis reveals why Zoetis stock may remain sluggish through June 2026, as weak triads weigh on its final phase.

 ubs-maintains-neutral-on-zoetis-lowers-price-target-to-158

UBS analyst Andrea Alfonso maintains Zoetis (NYSE:ZTS) with a Neutral and lowers the price target from $165 to $158.

 zoetis-announces-committee-for-veterinary-medicinal-products-of-the-ema-has-adopted-a-positive-opinion-recommending-the-granting-of-marketing-authorization-for-lenivia-for-the-reduction-of-pain-associated-with-osteoarthritis-in-dogs

Zoetis Inc. today announced that the Committee for Veterinary Medicinal Products (CVMP) of the European Medicines Agency (EMA) ...

 fda-conditionally-approves-first-drug-for-prevention-and-treatment-of-new-world-screwworm-infestations-in-cattle

https://www.fda.gov/news-events/press-announcements/fda-conditionally-approves-first-drug-prevention-and-treatment-new-world-sc...

 zoetis-receives-positive-opinion-from-cvmp-for-portela-to-alleviate-pain-associated-with-osteoarthritis-in-cats

https://www.ema.europa.eu/en/news/meeting-highlights-committee-veterinary-medicinal-products-cvmp-9-10-september-2025

 argus-research-reiterates-buy-on-zoetis-maintains-190-price-target

Argus Research analyst Jasper Hellweg reiterates Zoetis (NYSE:ZTS) with a Buy and maintains $190 price target.

Core News & Articles

https://www.sec.gov/Archives/edgar/data/1767640/000101143825000442/xslForm13F_X02/informationtable.xml

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION